{
    "title": "GSK 'firing on all cylinders' following bumper sales of new RSV vaccine",
    "url": "https://www.dailymail.co.uk/money/markets/article-12699249/GSK-firing-cylinders-following-bumper-sales-new-RSV-vaccine.html",
    "date": "2023-11-01",
    "keywords": [
        "gsk",
        "cent",
        "vaccine",
        "jab",
        "approval",
        "profit",
        "year",
        "walmsley",
        "quarter",
        "division",
        "rsv",
        "share",
        "account",
        "investment",
        "fund",
        "guidance",
        "company",
        "turnover",
        "consumer",
        "healthcare",
        "pfizer",
        "money",
        "diy",
        "market",
        "launch",
        "research",
        "product",
        "fee",
        "giant",
        "time",
        "breakthrough",
        "respiratory",
        "executive",
        "emma",
        "turnaround",
        "strategy",
        "jump",
        "operating",
        "rise",
        "haleon",
        "haleonthe",
        "pivot",
        "astrazeneca",
        "pandemicbut",
        "rollout",
        "food",
        "drug",
        "administration",
        "fda",
        "protection",
        "coldlike",
        "abrysvo",
        "pfizergsk",
        "fact",
        "pharmacy",
        "chain",
        "cvs",
        "summer",
        "fed",
        "interest",
        "alex",
        "brummer",
        "aston",
        "martin",
        "production",
        "car",
        "article",
        "competition",
        "opportunity",
        "population",
        "launcharexvy",
        "europe",
        "canada",
        "japan",
        "julywalmsley",
        "conversation",
        "government",
        "space",
        "deal",
        "partnership",
        "yearthe",
        "zhifei",
        "health",
        "performance",
        "growth",
        "head",
        "equity",
        "outlook",
        "development",
        "success",
        "valueruss",
        "director",
        "aj",
        "bell",
        "counterpart",
        "covid",
        "expertise",
        "intervening",
        "periodit",
        "update"
    ],
    "category": [
        "money",
        "markets"
    ]
}